Suppr超能文献

1 型糖尿病长期并发症累积发生率的关系:DCCT/EDIC 研究。

Relationships Between the Cumulative Incidences of Long-term Complications in Type 1 Diabetes: The DCCT/EDIC Study.

机构信息

Biostatistics Center, The George Washington University, Rockville, MD.

Division of Nephrology, University of Washington, Seattle, WA.

出版信息

Diabetes Care. 2023 Feb 1;46(2):361-368. doi: 10.2337/dc22-1744.

Abstract

OBJECTIVE

To describe the relationships between the cumulative incidences of long-term complications in individuals with type 1 diabetes (T1D) and assess whether observed associations are independent of age, duration of diabetes, and glycemic levels.

METHODS

Proliferative diabetic retinopathy (PDR), clinically significant macular edema (CSME), reduced estimated glomerular filtration rate (eGFR), amputations, cardiovascular disease (CVD), and mortality were assessed in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study over ∼30 years.

RESEARCH DESIGN AND RESULTS

The cumulative incidence of complications ranged from 3% (amputations) to 37% (CSME). There were large differences in the cumulative incidence of PDR between participants with versus without prior CSME (66% vs. 15%), reduced eGFR (59% vs. 29%), and amputation (68% vs. 32%); reduced eGFR with or without prior PDR (25% vs. 9%), amputation (48% vs. 13%), and CVD (30% vs. 11%); CVD with or without prior reduced eGFR (37% vs. 14%) and amputation (50% vs. 16%); and mortality with or without prior reduced eGFR (22% vs. 9%), amputation (35% vs. 8%), and CVD (25% vs. 8%). Adjusted for age, duration of T1D, and mean updated HbA1c, the complications and associations with higher risk included PDR with CSME (hazard ratio [HR] 1.88; 95% CI 1.42, 2.50), reduced eGFR (HR 1.41; 95% CI 1.01, 1.97), and CVD (HR 1.43; 95% CI 1.06, 1.92); CSME with higher risk of PDR (HR 3.94; 95% CI 3.18 4.89), reduced eGFR (HR 1.49; 95% CI 1.10, 2.01), and CVD (HR 1.35; 95% CI 1.03, 1.78); reduced eGFR with higher risk of CVD (HR 2.09; 95% CI 1.44, 3.03), and death (HR 3.40; 95% CI 2.35, 4.92); amputation(s) with death (HR 2.97; 95% CI 1.70, 2.90); and CVD with reduced eGFR (HR 1.59; 95% CI 1.08, 2.34) and death (HR 1.95; 95% CI 1.32, 2.90).

CONCLUSIONS

Long-term micro- and macrovascular complications and mortality are highly correlated. Age, diabetes duration, and glycemic levels do not completely explain these associations.

摘要

目的

描述 1 型糖尿病(T1D)患者长期并发症的累积发生率,并评估观察到的相关性是否独立于年龄、糖尿病病程和血糖水平。

方法

在糖尿病控制和并发症试验/糖尿病干预和并发症流行病学研究中,大约 30 年来评估了增殖性糖尿病视网膜病变(PDR)、临床显著黄斑水肿(CSME)、估算肾小球滤过率(eGFR)降低、截肢、心血管疾病(CVD)和死亡率。

研究设计和结果

并发症的累积发生率范围为 3%(截肢)至 37%(CSME)。有 CSME 的参与者与无 CSME 的参与者之间 PDR 的累积发生率存在很大差异(66%比 15%)、eGFR 降低(59%比 29%)和截肢(68%比 32%);有或没有先前 PDR 的 eGFR 降低(25%比 9%)、截肢(48%比 13%)和 CVD(30%比 11%);有或没有先前 eGFR 降低的 CVD(37%比 14%)和截肢(50%比 16%);有或没有先前 eGFR 降低的死亡率(22%比 9%)、截肢(35%比 8%)和 CVD(25%比 8%)。调整年龄、T1D 病程和平均更新 HbA1c 后,与更高风险相关的并发症包括 PDR 合并 CSME(风险比[HR]1.88;95%置信区间[CI]1.42,2.50)、eGFR 降低(HR 1.41;95% CI 1.01,1.97)和 CVD(HR 1.43;95% CI 1.06,1.92);CSME 与更高风险的 PDR(HR 3.94;95% CI 3.18 4.89)、eGFR 降低(HR 1.49;95% CI 1.10,2.01)和 CVD(HR 1.35;95% CI 1.03,1.78);eGFR 降低与更高风险的 CVD(HR 2.09;95% CI 1.44,3.03)和死亡(HR 3.40;95% CI 2.35,4.92)相关;截肢与死亡(HR 2.97;95% CI 1.70,2.90)相关;CVD 与 eGFR 降低(HR 1.59;95% CI 1.08,2.34)和死亡(HR 1.95;95% CI 1.32,2.90)相关。

结论

长期的微血管和大血管并发症和死亡率高度相关。年龄、糖尿病病程和血糖水平并不能完全解释这些关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c5a/9887612/35c421fd0319/dc221744F0GA.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验